Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Condition: AllergiesInterventions: Drug: Desloratadine; Drug: Zyrtec® (cetirizine)Sponsor: Merck Sharp & Dohme Corp.Completed - verified April 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials